Skip to main content
OpenTrials

Clinical trial condition

Stage IIA Breast Cancer

Explore clinical trials studying Stage IIA Breast Cancer. Study availability and eligibility vary by location and protocol.

43 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Stage IIA Breast Cancer trial results

Recruiting

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

NCT04553770

Conditions
Breast Diseases, Breast Neoplasms, Early-Stage Breast Cancer, +10 more
Locations
  • St. Joseph Heritage Healthcare Fullerton, California, United States
  • Cancer Blood and Specialty Clinic Los Alamitos, California, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Torrance Memorial Physician Network / Cancer Care Torrance, California, United States
View Trial Details
Completed

Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer

NCT01750073

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +20 more
Locations
  • Nebraska Medicine-Bellevue Bellevue, Nebraska, United States
  • CHI Health Saint Francis Grand Island, Nebraska, United States
  • Nebraska Medicine-Village Pointe Cancer Center Omaha, Nebraska, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Completed

Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer

NCT01730833

Conditions
Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • City of Hope- South Pasadena Cancer Center South Pasadena, California, United States
View Trial Details
Completed

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

NCT00066690

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive Breast Cancer, +11 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
View all 500 locations
View Trial Details
Completed

Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery

NCT02760030

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor and/or Progesterone Receptor Positive, +12 more
Locations
  • St. Elizabeth Healthcare Edgewood, Kentucky, United States
  • Case Western University Cleveland, Ohio, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer

NCT02400060

Conditions
Breast Carcinoma In Situ, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • Southeastern Medical Oncology Center-Goldsboro Goldsboro, North Carolina, United States
  • Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • Fletcher Allen Health Care-Medical Center Burlington, Vermont, United States
View Trial Details
Completed

Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery

NCT03188393

Conditions
Breast Diseases, Breast Neoplasms, Invasive Breast Carcinoma, +8 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 381 locations
View Trial Details

Related conditions